- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PTC596
Total 21 results
-
PTC TherapeuticsCompleted
-
Nationwide Children's HospitalPTC TherapeuticsActive, not recruitingHigh Grade Glioma | Diffuse Intrinsic Pontine GliomaUnited States
-
University of OklahomaPTC TherapeuticsActive, not recruitingOvarian CancerUnited States
-
PTC TherapeuticsRecruitingHuntington DiseaseAustralia, France, Germany, Netherlands, United Kingdom, Spain, Austria, Canada, Italy, New Zealand
-
PTC TherapeuticsUnited States Department of DefenseTerminated
-
Mimetica Pty LimitedUnknownAcne VulgarisUnited States
-
PTC TherapeuticsTerminatedLeukemia, Myeloid, Acute | AMLUnited States
-
PTC TherapeuticsRecruitingA Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)Huntington DiseaseUnited States, Austria, Spain, United Kingdom, Australia, France, Germany, Netherlands, Italy, New Zealand, Canada
-
Mimetica Pty LimitedCompletedSeborrhea | Oily SkinUnited States
-
Mimetica Pty LimitedCompleted
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); PTC TherapeuticsCompletedPTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System TumorsBrain and Central Nervous System TumorsUnited States
-
PTC TherapeuticsTerminatedCOVID-19 | Pneumonia | CoronavirusSpain, United States, Australia, France, Brazil, Mexico, South Africa, Belgium, Colombia, Poland, Portugal
-
PTC TherapeuticsActive, not recruitingLeiomyosarcomaUnited States, United Kingdom, France, Italy, Netherlands, Spain, Australia, Canada, Brazil, Germany, Hungary, Poland
-
PTC TherapeuticsCompletedLeiomyosarcomaUnited States
-
Icahn School of Medicine at Mount SinaiActive, not recruitingLocally Advanced HPV Positive Oropharynx CancerUnited States
-
PTC TherapeuticsUnited States Department of DefenseCompletedMetastatic Breast CancerUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLC; PTC TherapeuticsTerminated
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | NHL | High-grade B-cell LymphomaUnited States
-
Fate TherapeuticsTerminatedLymphoma, B-Cell | Chronic Lymphocytic LeukemiaUnited States
-
Fate TherapeuticsWithdrawnFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Transformed Indolent Non-Hodgkin's Lymphoma